Gc. Weir et al., TRANSCRIPTION FACTOR ABNORMALITIES AS A CAUSE OF BETA-CELL DYSFUNCTION IN DIABETES - A HYPOTHESIS, Acta diabetologica, 34(3), 1997, pp. 177-184
Well-characterized defects in insulin secretion, most notably a loss o
f glucose-induced insulin secretion, are found in virtually all forms
of NIDDM, as well as in early IDDM. Similar abnormalities have been fo
und in all animal models of diabetes in which they have been studied.
A novel hypothesis is being proposed to explain the mechanisms respons
ible for these alterations. Many abnormalities in the various steps of
glucose-induced insulin secretion have been identified in rodent mode
ls of diabetes, but none by itself seems sufficient to explain the def
ects. These include a loss of GLUT2, glycogen accumulation, glucose re
cycling, abnormal glucokinase or hexokinase, altered mitochondrial gly
cerol phosphate dehydrogenase (mGPDH) activity, abnormal ion channel f
unction and beta cell degranulation. We propose that optimal secretory
function is dependent upon the unique differentiation of beta cells t
hat is maintained by a set of transcription factors and that this cont
rol is disrupted by the diabetic state. Therefore, we propose that key
transcription factors are affected even when beta cells are stressed
by insulin resistance in very earliest stages of diabetes and that the
abnormality becomes more severe as full-blown diabetes develops, whic
h leads to loss of beta cell differentiation and a resultant derangeme
nt of insulin secretion.